Evidence map›Paper›PMID 40476102›Full record

ArticleCureus2025

Progressive Supranuclear Palsy: Clinical Features and Neuroimaging in a Case Series.

Favio M Fimbres-Laborin, Roger Carrillo-Mezo, Ricardo Lopez de la Cruz, Marie-Catherine Boll

Abstract read
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Favio M Fimbres-LaborinClinical Research Laboratory, Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez (MVS), Mexico City, MEX.
Roger Carrillo-MezoNeuroradiology, Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez (MVS), Mexico City, MEX.
Ricardo Lopez de la CruzClinical Research Laboratory, Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez (MVS), Mexico City, MEX.
Marie-Catherine BollClinical Research Laboratory, Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez (MVS), Mexico City, MEX.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Progressive supranuclear palsy (PSP), a neurodegenerative disease with remarkable clinical diversity, lacks early and robust biomarkers to confirm the diagnosis in vivo. Given this, we analyzed magnetic resonance imaging studies in a series of patients admitted to a referral center after a comprehensive clinical examination. We had access to the complete clinical and radiologic data of 12 PSP patients. In all cases, initial symptoms included gait and speech abnormalities. A functional scale assessment was performed prior to visual assessment of neuroimaging studies and planimetric analysis. We found potentially useful neuroimaging-based indices derived from brainstem and ventricular measurements. When examining correlations between these indices and the most affected clinical domains of the disease, we observed that higher values in specific measurements involving the pons area and cerebellar peduncles were significantly correlated with more severe impairment in gait and speech in our case series.

Indexed as

clinical deficits scaleimaging biomarkersmrpimrpi2.0p/mprogressive supranuclear palsysuperior cerebellar peduncle

Identifiers

PMID40476102
PMCPMC12140374

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.